Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling system
Sakae Tanaka(The University of Tokyo), Tatsuo Suda(SHOWA Medical University), Naoyuki Takahasi(Matsumoto Dental University), Kozo Nakamura(The University of Tokyo)
Cited by 324
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study
|Journal of Bone and Mineral Metabolism|2009|820
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665